Laevolac

Lactulose, the active ingredient in Laevolac, is an osmotic laxative presented as an oral solution for oral use. It is employed to relieve constipation and to reduce ammonia levels in patients with hepatic encephalopathy, particularly in adult and pediatric populations where indicated.

GNH USA supplies Laevolac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable lead times and dedicated technical support throughout the procurement process.

Laevolac (lactulose) is used in the gastrointestinal and hepatic pathways to manage specific conditions.

Constipation: alleviates hard stools and promotes regular bowel movements. Hepatic encephalopathy: lowers blood ammonia by enhancing colonic excretion, helping to improve mental status.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Diarrhea: loose stools, especially at higher doses. - Nausea: feeling of sickness.

Serious or Rare Side Effects: - Electrolyte imbalance: loss of potassium or sodium causing weakness. - Severe dehydration: excessive fluid loss leading to dizziness or low blood pressure. - Allergic reaction: rash, itching or swelling indicating hypersensitivity.

When prescribing Laevolac, clinicians should consider several precautionary measures to ensure safe use. - Dose titration: start with the lowest effective dose and adjust based on response. - Fluid intake: maintain adequate hydration to reduce risk of dehydration. - Renal impairment: monitor kidney function, as reduced clearance may increase osmotic load. - Diabetes mellitus: monitor blood glucose, as lactulose may affect carbohydrate metabolism. - Pediatric use: use under pediatric specialist guidance, adjusting dose for age and weight. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Lactulose can interact with other medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce lactulose’s osmotic effect. - Antibiotics (e.g., rifaximin): concurrent use may alter gut flora and affect ammonia reduction.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte disturbances. - Insulin or oral hypoglycemics: monitor blood glucose as lactulose can affect carbohydrate absorption. - Oral potassium supplements: may be affected by changes in intestinal pH.